Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target
Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
Stocks · News reference
Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $20.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Equillium shares are trading higher after the company reported better-than-expected Q2 EPS results.
Equillium Q2 EPS $(0.04) Beats $(0.05) Estimate
8-K filing — Equillium, Inc. (EQ)
Filed: 2026-08-13 AccNo: 0001193125-26-349182 Size: 770 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits